PT  - JOURNAL ARTICLE
AU  - Vsevolod E. Kostrubsky
AU  - Jacqueline F. Sinclair
AU  - Vinod Ramachandran
AU  - Raman Venkataramanan
AU  - Yuan Hua Wen
AU  - Erick Kindt
AU  - Vladimir Galchev
AU  - Kelly Rose
AU  - Michael Sinz
AU  - Stephen C. Strom
TI  - The Role of Conjugation in Hepatotoxicity of Troglitazone in Human and Porcine Hepatocyte Cultures
DP  - 2000 Oct 01
TA  - Drug Metabolism and Disposition
PG  - 1192--1197
VI  - 28
IP  - 10
4099  - http://dmd.aspetjournals.org/content/28/10/1192.short
4100  - http://dmd.aspetjournals.org/content/28/10/1192.full
SO  - Drug Metab Dispos2000 Oct 01; 28
AB  - In primary human and porcine hepatocyte cultures, we investigated the relationship between metabolism and cytotoxicity of troglitazone. Treatment of human hepatocytes for 2 h with 10, 20, 25, 35, and 50 μM troglitazone in protein-free medium resulted in concentration-dependent decreases in total protein synthesis. Decreases at 10 and 20 μM were reversible by 24 h, however protein synthesis did not recover at concentrations ≥25 μM. Troglitazone at 50 μM caused cellular death. In porcine hepatocytes, 100 μM troglitazone was lethal, whereas at 50 μM, protein synthesis completely recovered by 24 h. Recovery in protein synthesis was associated with metabolism of parent drug, whereas toxicity correlated (r2 = 0.82) with accumulation of unmetabolized troglitazone. By 1 h, in human hepatocytes, troglitazone was metabolized to similar amounts of sulfate and quinone metabolites with little glucuronide detected. In contrast, porcine hepatocytes metabolized troglitazone to the similar amounts of glucuronide and the quinone metabolites with little sulfate detected. Exposure of human hepatocytes to a combination of 10 μM troglitazone and 10 μM 2,4-dichloro-4-nitrophenol resulted in a 70% decrease in protein synthesis, associated with 90% inhibition in the formation of troglitazone sulfate, a 4-fold increase in unmetabolized troglitazone, and no effect on formation of the quinone metabolite. Treatment with a combination of acetaminophen or phenobarbital with 20 μM troglitazone resulted in sustained decrease in protein synthesis associated with inhibition of sulfation and accumulation of troglitazone. These results suggest that inhibition of troglitazone sulfation may result in increased hepatotoxicity due to exposure to parent drug, or increased metabolism by alternate pathways. The American Society for Pharmacology and Experimental Therapeutics